Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein

被引:1
作者
Gugliucci, Alejandro [1 ]
Caccavello, Russell [1 ]
Kotani, Kazuhiko [2 ]
Kimura, Satoshi [3 ,4 ]
机构
[1] Touro Univ Calif, Coll Osteopath Med, Glycat Oxidat & Dis Lab, Vallejo, CA 94592 USA
[2] Jichi Med Univ, Dept Clin Lab Med, Mibu, Tochigi, Japan
[3] Showa Univ, Northern Yokohama Hosp, Dept Lab Med, Yokohama, Kanagawa, Japan
[4] Showa Univ, Northern Yokohama Hosp, Cent Clin Lab, Yokohama, Kanagawa, Japan
关键词
Small-dense LDL; Paraoxonase; 1; Oxidative stress; Atherosclerosis; HDL SUBCLASSES; LDL OXIDATION; PON1; DISEASE; RISK; LACTONASES; PROTECTION; PROTEOMICS;
D O I
10.1179/1351000214Y.0000000084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: We have recently demonstrated the quick ex vivo transfer of paraoxonase 1 (PON1) activity from high-density lipoprotein (HDL) to small, dense low-density lipoprotein (sdLDL). We set out to assess whether sdLDL contains active PON1 in vivo. Methods: We conducted a nested case-control, proof of principle study with the Japanese healthy subjects with normal lipids (n = 23) and age and gender-paired dyslipidemic subjects (n = 17). Lipid panels, lactonase and arylesterase assays, and PON1 zymogram in the LDL and HDL subclasses were assessed. Results: PON1 specific activity in the high-molecular weight lipoprotein fraction corresponding to LDL migration was found in 48% of normo and in 29% of dyslipidemic Japanese subjects. This band co-localizes with apoB100 and not Lp(a) and displays a lower molecular mass than the bulk of LDL. Conclusion: We provide evidence, for the first time, that native sdLDL contains up to 4% of the total PON1 activity in the serum of up to 48% of the Japanese subjects. Could the PON1-containing sdLDL represent a set of particles with a defense mechanism from oxidation and therefore its levels actually prove to be atheroprotective? If further studies confirm this contention, a zymogram of PON1 in LDL subclasses could be a functional assay that complements the current methods that only inform on the size and lipid concentration of these particles.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 34 条
  • [1] Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
    Aharoni, Saar
    Aviram, Michael
    Fuhrman, Bianca
    [J]. ATHEROSCLEROSIS, 2013, 228 (02) : 353 - 361
  • [2] Alabakovska SB, 2008, BRATISL MED J, V109, P155
  • [3] Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians
    Alabakovska, SB
    Todorova, BB
    Labudovic, DD
    Tosheska, KN
    [J]. CLINICA CHIMICA ACTA, 2002, 317 (1-2) : 119 - 123
  • [4] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [5] LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants
    Aviram, M
    Fuhrman, B
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) : 149 - 159
  • [6] Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R
    Aviram, M
    Billecke, S
    Sorenson, R
    Bisgaier, C
    Newton, R
    Rosenblat, M
    Erogul, J
    Hsu, C
    Dunlop, C
    La Du, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) : 1617 - 1624
  • [7] Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion
    Aviram, Michael
    Vaya, Jacob
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (04) : 339 - 344
  • [8] Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results
    Camps, Jordi
    Mackness, Michael
    Mackness, Bharti
    Marsillach, Judit
    Joven, Jorge
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (06) : 893 - 894
  • [9] Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis
    Caulfield, Michael P.
    Li, Shuguang
    Lee, Gloria
    Blanche, Patricia J.
    Salarneh, Wael A.
    Benner, W. Henry
    Reitz, Richard E.
    Krauss, Ronald M.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (08) : 1307 - 1316
  • [10] Costa Lucio G, 2005, Acta Biomed, V76 Suppl 2, P50